Innoviva (INVA) Free Cash Flow (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 220.60% |
| Jun 30, 2025 | -9.35% |
| Sep 30, 2024 | 195.49% |
| Jun 30, 2024 | 18.01% |
| Sep 30, 2023 | 181.67% |
| Jun 30, 2023 | 48.85% |
| Sep 30, 2022 | 143.98% |
| Jun 30, 2022 | -19.44% |
| Sep 30, 2021 | 213.70% |
| Jun 30, 2021 | 0.60% |
| Mar 31, 2021 | -1.38% |
| Dec 31, 2020 | 14.38% |
| Sep 30, 2020 | -6.56% |
| Jun 30, 2020 | 8.61% |
| Mar 31, 2020 | 9.83% |
| Dec 31, 2019 | 16.53% |
| Sep 30, 2019 | 1.60% |
| Jun 30, 2019 | -26.30% |
| Mar 31, 2019 | 24.08% |
| Dec 31, 2018 | 2.76% |
| Sep 30, 2018 | 16.22% |
| Jun 30, 2018 | 3.63% |
| Mar 31, 2018 | 4.29% |
| Dec 31, 2017 | 10.05% |
| Sep 30, 2017 | 92.10% |
| Jun 30, 2017 | -18.45% |
| Mar 31, 2017 | 31.83% |
| Dec 31, 2016 | 5.58% |
| Sep 30, 2016 | 60.18% |
| Jun 30, 2016 | 71.75% |
| Mar 31, 2016 | 4.83% |
| Dec 31, 2015 | 160.39% |
| Sep 30, 2015 | 22.17% |
| Jun 30, 2015 | 234.03% |
| Mar 31, 2015 | 65.80% |
| Dec 31, 2014 | 77.49% |
| Sep 30, 2014 | 60.50% |
| Jun 30, 2014 | -2.07% |
| Mar 31, 2014 | -27.33% |
| Dec 31, 2013 | 1.22% |
| Sep 30, 2013 | -139.09% |
| Jun 30, 2013 | 46.32% |
| Mar 31, 2013 | -32.06% |
| Dec 31, 2012 | 12.86% |
| Sep 30, 2012 | 19.68% |
| Jun 30, 2012 | 17.45% |
| Mar 31, 2012 | -61.57% |
| Dec 31, 2011 | -36.12% |
| Sep 30, 2011 | -0.79% |
| Jun 30, 2011 | 29.81% |
| Mar 31, 2011 | -74.31% |
| Dec 31, 2010 | 19.10% |